Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 30.667M	--
--	2024/Q4	-- / 11.700M	--
Nov 12, 2024	2024/Q3	49.412M / 25.071M	--
Aug 6, 2024	2024/Q2	356.000K / 8.260M	--
May 9, 2024	2024/Q1	481.000K / 6.361M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 30.667M--

--2024/Q4-- / 11.700M--

Nov 12, 20242024/Q349.412M / 25.071M--

Aug 6, 20242024/Q2356.000K / 8.260M--

May 9, 20242024/Q1481.000K / 6.361M--

Unlock Free Earnings Estimates

Open Account

Sangamo Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 12, 2024 16:09 ET

Sangamo Therapeutics | 8-K: SANGAMO THERAPEUTICS REPORTS RECENT BUSINESS HIGHLIGHTS AND THIRD QUARTER 2024 FINANCIAL RESULTS

Nov 12, 2024 16:06 ET

Sangamo Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 6, 2024 16:07 ET

Sangamo Therapeutics | 8-K: SANGAMO THERAPEUTICS REPORTS RECENT BUSINESS HIGHLIGHTS AND SECOND QUARTER 2024 FINANCIAL RESULTS

Aug 6, 2024 16:06 ET

Symbol Mini Chart % Chg

Unlock the Full List

Analysis

Updated: Feb 12, 2025

Strong Buy

No Data